Instrument Inactif

Communiqués Medovex Corp OTC Bulletin Board

Actions

Cours en clôture OTC Bulletin Board Autres places de cotation
- ^USD	-

02/07	Innoveren Scientific Inc. annonce la démission de William Horne en tant que membre du conseil d'administration	CI
06/03	Innoveren Scientific annonce le dépôt d'une demande 510(K) auprès de la Federal Food and Drug Administration américaine pour le Skindisc(Tm) Lite	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Innoveren Scientific : Announces Corporate Update - Form 8-K	22/05	PU
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	18/04/23	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/03/23	AQ
H-CYTE Completes Acquisition of SkinDisc™ Regenerative Tissue Kit from Scion Solutions, LLC	29/12/22	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	28/12/22	AQ
H-CYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/11/22	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	07/10/22	AQ
H-CYTE Announces Intent to Acquire SkinDisc, Expects to Complete Within 30 Days	19/09/22	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	14/09/22	AQ
H-CYTE Completes Acquisition of Jantibody	08/09/22	AQ
H-CYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	12/08/22	AQ
H-CYTE to Expect the Completed Acquisition of Jantibody Within 30 Days	22/07/22	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	16/06/22	AQ
H-CYTE Announces 1-for-1,000 Reverse Stock Split	13/06/22	AQ
H-CYTE, INC. : Other Events (form 8-K)	09/06/22	AQ
H-CYTE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial Statements and Exhibits (form 8-K)	10/05/22	AQ
H-CYTE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	04/05/22	AQ
H-CYTE, INC. : Other Events (form 8-K)	04/04/22	AQ
H-CYTE Announces Proceeds of $1.05 Million from Warrant Exercise	04/03/22	AQ
H-CYTE, INC. : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	02/03/22	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Medovex Corp OTC Bulletin Board

Actions

Communiqués

Filtres